Courtesy of Benzinga. Maxygen, Inc. (Nasdaq: MAXY), a biotechnology company, today announced that its Board of Directors has approved an increase to the...(read more
A little over a year ago in April 2010,
Maxygen, Inc. (MAXY:
spun out its Codexis-branded biocatalyst business amid great expectations for getting a better valuation...(read more
Maxygen (MAXY) shares surged on Thursday amid news that its joint venture interest in Perseid Therapeutics is being acquired by Astellas Pharma for $76 million.
According to their joint...(read more